Canadian Cancer Trials Group shared a post on LinkedIn:
“Melanoma clinical trial ME17 is officially open for enrollment in Canada. The study will compare immunotherapy alone with adding FMT treatment to the immunotherapy to improve outcomes.
Canadian Cancer Trials Group shared a post on LinkedIn:
“Melanoma clinical trial ME17 is officially open for enrollment in Canada. The study will compare immunotherapy alone with adding FMT treatment to the immunotherapy to improve outcomes.